Corpus Intelligence IC Memo — TRINITY BETTENDORF 2026-04-26 03:50 UTC
IC Memo — TRINITY BETTENDORF
Investment Committee Memorandum | IA | 81 beds | Grade C | EBITDA uplift $6.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TRINITY BETTENDORF

CCN 160104 | SCOTT, IA | 81 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TRINITY BETTENDORF is a 81-bed suburban community hospital in SCOTT, IA with $90.6M in net patient revenue and a -3.7% operating margin. The hospital serves a payer mix of 21.3% Medicare, 1.8% Medicaid, and 76.9% commercial.

Thesis: Turnaround. Our ML models identify $6.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.7% to 3.7% (+736bps).

Net Revenue HCRIS$90.6M
Current EBITDA COMPUTED$-3.3M
Operating Margin COMPUTED-3.7%
Occupancy HCRIS52.5%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS29.2%
Distress Probability ML46.7%

2. Market Context & Competitive Position

124
IA Hospitals
-8.2%
State Median Margin
22
Comparable Hospitals

IA has 124 Medicare-certified hospitals with a median operating margin of -8.2%. The target's margin of -3.7% places it above the state median. Among 22 size-comparable peers (40-162 beds), the median margin is -17.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-162), prioritizing same-state peers. 22 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TRINITY BETTENDORF (Target)IA81$90.6M-3.7%
MERCYONE WATERLOO MEDICAL CENTIA134$283.3M-5.1%
MARY GREELEY MEDICAL CENTERIA150$220.4M-3.6%
BROADLAWNS MEDICAL CENTERIA113$169.5M-37.0%
MERCYONE DUBUQUE MEDICAL CENTEIA142$152.7M-25.8%
MERCYONE SIOUXLAND MEDICAL CENIA125$148.2M-40.8%
TRINITY REGIONAL MEDICAL CENTEIA44$140.4M-6.8%
THE FINLEY HOSPITALIA66$121.7M0.1%
JENNIE EDMUNDSON MEMORIALIA127$121.6M-5.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.9M+210bp18mo
Cost to Collect4.5%2.5%$1.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.1M+122bp9mo
Clean Claim Rate88.0%96.0%$58K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.9M
Cost to Collect
$1.8M
Denial Rate Reduction
$1.8M
A/R Days Reduction
$1.1M
Clean Claim Rate
$58K
Total EBITDA Uplift$6.7M
Current EBITDA$-3.3M
+ RCM Uplift+$6.7M
Pro Forma EBITDA$3.3M
Current Margin-3.7%
Pro Forma Margin3.7%
WC Released (1x)$3.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.1M$44.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.1M$47.5M0.00x-100.0%
Bull Case9.0x11.0x$-4.6M$67.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.6M$72.6M0.00x-100.0%
Bear Case11.0x10.0x$-5.6M$13.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.6M$12.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 22 hospitals with 40-162 beds
  • Same-state prioritization (n=23)
  • Comp margins: P25=-24.5% / P50=-17.4% / P75=-5.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.